Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: The metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF)

JAMA

Volumn 283, Issue 10, 2000, Pages 1295-1302

  Hjalmarson, Åke ^b   Goldstein, Sidney ^d   Fagerberg, Björn ^a   Wedel, Hans ^c   Waagstein, Finn ^b   Kjekshus, John ^e   Wikstrand, John ^a   El Allaf, Dia ^g   Vítovec, Jirí ^h   Aldershvile, Jan ⁱ   Halinen, Matti ^j   Dietz, Rainer ^k   Neuhaus, Karl Ludwig ^l   Jánosi, András ^m   Thorgeirsson, Gudmundur ⁿ   Dunselman, Peter H J M ^o   Gullestad, Lars ^f   Kuch, Jerzy ^p   Herlitz, Johan ^b   Riekenbacher, Peter ^q   Ball, Stephen ^r   Gottlieb, Stephen ^s   Deedwania, Prakash ^t   more..

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Department of Cardiology ^*  (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d HENRY FORD HOSPITAL   (United States)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f Baerums Sykehus   (Norway)

^g Centre Hospitalier Hutois   (Belgium)

^h UNIVERSITY HOSPITAL BRNO   (Czech Republic)

ⁱ Rigshospitalet   (Denmark)

^j KUOPIO UNIVERSITY HOSPITAL   (Finland)

^k CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^l KLINIKUM KASSEL   (Germany)

^m ST JOHN'S HOSPITAL   (Hungary)

ⁿ LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^o Ignatius Hospital   (Netherlands)

^p MEDICAL UNIVERSITY OF WARSAW   (Poland)

^q Kantonsspital Bruderholz   (Switzerland)

^r LEEDS GENERAL INFIRMARY   (United Kingdom)

^s UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^t VETERANS AFFAIRS MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

METOPROLOL;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BRADYCARDIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DYSPNEA; FATIGUE; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HOSPITALIZATION; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; VERTIGO;

EID: 0034104565     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.283.10.1295     Document Type: Article

References (25)

1. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: trends in incidence and survival in a 10-year period. Arch Intern Med. 1999;159:29-34.
2. Krumholz HM, Parent EM, Tu N, et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med. 1997; 157:99-104.
3. Narang R, Cleland JGF, Erhardt L, et al. Mode of death in chronic heart failure: a request and proposition for more accurate classification. Eur Heart J. 1996; 17:1390-1403.
4. Steering Committee and Membership of the Advisory Council to Improve Outcomes Nationwide in Heart Failure. Consensus recommendations for the management of chronic heart failure. Am J Cardiol. 1999;83:2A-38A.
5. Garg RG, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA. 1995;273:1450-1456.
6. Heidenrich PA, Lee TT, Massie BM. Effect of betablockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. J Am Coll Cardiol. 1997;30:27-34.
7. Packer M, Bristow MR, Cohn JN, et al.The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-1355.
8. Australia/New Zealand Heart Failure Research Collaborative Group. Randomized, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet. 1997;349:375-380.
9. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS II). Lancet 1999;353:9-13.
10. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial In Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001-2007.
11. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observations of each patient, I: introduction and design. Br J Cancer. 1976;34:585-612.
12. The International Steering Committee for the MERIT-HF Study Group. Rationale, design, and organisation of the metoprolol CR/XL randomized trial in heart failure (MERIT-HF). Am J Cardiol. 1997;80:54J-58J.
13. Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Am Heart J. 1992;124:1017-1025.
14. Juniper EF, Guyatt GH, WillanA, Griffith LE. Determining the minimal important change in a disease-specific QoL questionnaire. J Clin Epidemiol. 1994;47:81-87.
15. Waagstein F, Wahlqvist I, Andersson B, et al. Metoprolol prevents left ventricular dilatation and increases exercise ejection fraction to the same extent in idiopathic and ischemic cardiomyopathy [abstract] Eur Heart J. 1998;19(suppl):307.
16. Andersson B, Blomstrom-Lundqvist C, Hedner T, Waagstein F. Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure. J Am Coll Cardiol. 1991;18:1059-1066.
17. Waagstein F, Bristow MR, Swedberg K, et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet. 1993;342:1441-1446.
18. The Metoprolol in Dilated Cardiomyopathy Trial Study Group. Three-year follow-up of patients randomized in the Metoprolol in Dilated Cardiomyopathy Trial. Lancet. 1998;351:1180-1181.
19. Fischer D, Stewart AL, Bloch DA, Lorig K, Laurent D, Holman H. Capturing the patient's view of change as a clinical outcome measure. JAMA. 1999; 282:1157-1162.
20. Colucci WS, Packer M, Bristow MR, et al. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. Circulation. 1996;94:2800-2806.
21. Cohn JN, Fowler MB, Bristow MR, et al. Safety and efficacy of carvedilol in severe heart failure. J Card Fail. 1997;3:173-179.
22. Packer M, Colucci WS, Sackner-Bernstein JD, et al. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure: the PRECISE Trial. Circulation. 1996; 94:2793-2799.
23. Sandberg A, Ragnarsson G, Jonsson UE, Sjögren J. Design of a new multiple-unit controlled-release formulation of metoprolol - metoprolol CR/XL. Eur J Clin Pharmacol. 1988;33(suppl):S3-S7.
24. Andersson B, Åberg J. The effect on heart rate of immediate and slow-release metoprolol in patients with chronic heart failure [abstract]. J Am Coll Cardiol. 1999; 33:183A-184A.
25. Krum H, Whorlow S. Meta-analysis of effect of betablocker therapy on mortality in NYHA class IV CHF patients [abstract]. Circulation. 1999;100(suppl I):I203.